AACR 2024 | Challenges in implementing liquid biopsies for head and neck cancer

Mouadh Barbirou, PhD, Thomas Jefferson University, Philadelphia, PA, provides an overview of remaining hurdles in implementing liquid biopsies for head and neck cancer in the clinic, such as the lack of reliable data in the field. Whilst circulating tumor DNA (ctDNA) is predominantly used for liquid biopsies, exosomes extracted from saliva and plasma are a promising avenue. However, collection and purification of exosomes need to further enhanced. This interview took place at American Association for Cancer Research (AACR) Annual Meeting 2024 in San Diego, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.